AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2007
Mar 13, 2007
33510_dirs_2007-03-13_b9b27e8e-fcf3-4b6f-a98b-78c3c87f4d78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IsoRay, Inc. (ISRY.OB)
CIK: 0000728387
Period of Report: 2007-02-14
Reporting Person: Woods Lori A (Vice President)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| common stock | 3000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| stock option (right to buy) | $3.5 | 2016-07-05 | common stock (50000) | Direct | |
| stock option (right to buy) | $3.1 | 2016-10-17 | common stock (50000) | Direct | |
| stock options (right to buy) | $4.4 | 2017-03-02 | common stock (15000) | Direct |
Footnotes
F1: 16,666 stock options vest 07/05/2007, 16,667 stock options vest 07/05/2008, 16,667 stock options vest 07/05/2009
F2: 16,666 stock options vest 10/17/2007, 16,667 stock options vest 10/17/2008, 16,667 stock options vest 10/17/2009
F3: 5,000 stock options vest 03/02/2008, 5,000 stock options vest 03/02/2009, 5,000 stock options vest 03/02/2010
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16